Portfolio Lab

Davita Inc.

  • Stock
  • Ticker DVA
  • ISIN US23918K1088
  • NYSE

Health care · Health care services · USA

$161.03 +3.00%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Davita Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

DVAGlobal equities (VT)

$10,000 grew to $25,621. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −51.1% in 11/2022, measured from the peak in 08/2021. It took 31 months to get back to the old peak.

1-year return
+39.6%
5-year return p.a.
+10.1%
10-year return p.a.
+9.9%
Volatility p.a.
36.9%
Largest decline
−51.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue3,2953,2243,3803,4203,6203,4163,5543,578
Operating income565439538506561482579499
EBITDA732615713683741660747664
Net income259163199150234198265223
Earnings per share3.072.002.582.043.222.874.023.40
Balance sheet
Total assets17,28517,11917,49317,55617,48017,49917,70917,817
Liabilities15,19415,45915,94016,21516,32216,45116,63016,691
Equity121-267-370-572-651-755-765-591
Cash795439708706676644669496
Cash flow
Operating cash flow548180324842541321490519
Capital expenditure-171-143-121-166-145-102-170-159
Free cash flow37737203675395219320359

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2020 at +56.5%, weakest 2022 at −34.4%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
29 Oct 2026$3.40
4 Aug 2026$4.02
5 May 2026$2.87
11 Feb 2026$3.22
29 Oct 2025$2.04
5 Aug 2025$2.58
12 May 2025$2.00
13 Feb 2025$3.07
29 Oct 2024$2.50
6 Aug 2024$2.50
2 May 2024$2.65
14 Feb 2024$1.62

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€9.2bn
Market cap in trading currency
$10.1bn
Enterprise value
$9.56bn
P/E
11.9
P/S
0.71
P/B
–
EV/Sales
0.67
EV/EBITDA
3.4
Earnings yield
8.4%
FCF yield
12.8%

Results (last four quarters)

Revenue
$14.2bn
Gross profit
–
EBITDA
$2.81bn
Net income
$920m
Earnings per share
$13.51
Revenue per share
$225.24
Revenue growth
+4.6%
Earnings growth
+48.3%

Profitability

Gross margin
–
Operating margin
15.0%
Net margin
6.5%
Return on equity
–
Return on assets
5.2%

Balance sheet and cash flow

Cash
$566m
Cash per share
$9.00
Financial debt
–
Debt/equity %
–
Current ratio
1.41
Book value per share
−$9.40
Operating cash flow
$1.87bn
Free cash flow
$1.29bn

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
62.9m
Volume
697,193
Avg. volume 3 months
718,540
Relative volume
0.9

Price and technicals

Price
$161.03
1 day
+3.0%
52-week high
$240.96
52-week low
$103.87
Distance to 52-week high
−33.2%
Distance to 52-week low
+55.0%
Distance to 50-day line
−11.0%
Distance to 200-day line
−11.4%
RSI (14)
36
Volatility 1M
48.9%

Performance

1 week
−7.8%
1 month
−13.5%
3 months
−8.8%
6 months
−18.9%
YTD
+41.7%
1 year
+39.8%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has DVA performed since 11/2016?

$10,000 grew to $25,621 by 20 Nov 2026, which is +9.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is DVA?

Volatility was 36.9% per year, measured on monthly returns. The largest decline from a peak was −51.1%, with the low in 11/2022.

How does DVA compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, DVA returned +9.9% at 36.9%. The correlation of monthly returns was 0.46; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Davita Inc. (DVA): Return and risk | Portfolio Lab